Silexion Therapeutics Corp - Warrants(14/08/2029)
SLXNW
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.05M
Close$
Share Statistics
| Market cap | $2.05 Million |
|---|---|
| Enterprise Value | $76,271.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-89.6 |
| Beta | -0.29 |
| Outstanding Shares | 323,037 |
Return
| Return on Equity | -316.15% |
|---|---|
| Return on Assets | -19.99% |
| Return on Invested Capital | -1274.91% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | -0.21 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 5.72 |
| Debt to Equity | 1.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-1.29
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-13.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 26,6830% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 74.83%▼ 132.67% |
|---|---|
| Total Invested | $61,971▼ 25.44% |
| Investors Holding | 21▼ 2.00% |
ESG Score
No data